- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02123394
Efficacy of the Mckenzie Method in Patients With Chronic Non-Specific Low Back Pain (Mckenzie)
Efficacy of the Mckenzie Method in Patients With Chronic Non-Specific Low Back Pain: A Randomized Placebo-Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
One hundred and forty-eight patients will be randomly allocated to two treatment groups: McKenzie method or Placebo (detuned ultrasound and short wave therapy) for 5 weeks (total of 10 sessions of 30 minutes each).
The clinical outcomes will be obtained at the completion of treatment (5 weeks) and at 3, 6, and 12 months after randomization. The data will be collected by a blinded assessor. The statistical analysis will follow the intention-to-treat principles and the between-group differences will be calculated by constructing mixed linear models.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
SP
-
Sao Paulo, SP, Brazil, 03071-000
- Universidade Cidade de Sao Paulo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: patients seeking care for chronic non-specific low back pain (defined as pain or discomfort between the costal margins and the inferior gluteal folds, with or without referred symptoms in the lower limbs, for at least 3 months), with a pain intensity of at least 3 points measured by a 0-10 points pain numerical rating scale, aged between 18 and 80 years and able to read in Portuguese.
-
Exclusion Criteria: patients will be excluded if they have any contraindication to physical exercise or ultrasound or short wave therapy, evidence of nerve root compromise (i.e one or more of motor, reflex or sensation deficit), serious spinal pathology (such as fracture, tumor, inflammatory and infectious diseases), serious cardiovascular and metabolic diseases, previous back surgery and pregnancy.
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: Placebo
The patients allocated to the Placebo group will be treated with detuned pulsed ultrasound for 5 minutes and detuned short wave diathermy in pulsed mode for 25 minutes.
Patients will receive 10 sessions of treatment over a period of five weeks (two sessions/week).
|
The patients allocated to the Placebo group will be treated with detuned pulsed ultrasound therapy for 5 minutes and detuned short wave diathermy in pulsed mode for 25 minutes.
Patients will receive 10 sessions of treatment over a period of five weeks (two sessions/week).
Other Names:
|
EXPERIMENTAL: McKenzie method
The patients of the McKenzie group will be treated according to the principles of the method and the choice of therapeutic intervention will be guided by the physical examination findings and classification.
Patients will also receive written instructions from the Treat Your Own Back book and will be asked to perform home exercises based on the principles of McKenzie method.
Patients will receive 10 sessions of treatment over a period of five weeks (two sessions/week).
|
The patients of the McKenzie group will be treated according to the principles of the method and the choice of therapeutic intervention will be guided by the physical examination findings and classification.
Patients will also receive written instructions from the Treat Your Own Back book and will be asked to perform home exercises based on the principles of McKenzie method.
The description of the exercises that will be prescribed in this study are already published elsewhere.
Compliance with home exercises will be monitored by means of a daily-log that the patient will fill in at home and bring to the therapist at each subsequent session.
Patients will receive 10 sessions of treatment over a period of five weeks (two sessions/week).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain Intensity
Time Frame: 5 weeks after randomization
|
Pain Intensity will be measured by an 11-point (0-10) Numerical Rating Scale (Pain NRS)
|
5 weeks after randomization
|
Disability
Time Frame: Five weeks after randomization
|
Disability will be measured by the 24-item Roland Morris Disability Questionnaire
|
Five weeks after randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Disability
Time Frame: 3, 6 and 12 months after randomization
|
Disability will be measured by the 24-item Roland Morris Disability Questionnaire
|
3, 6 and 12 months after randomization
|
Pain Intensity
Time Frame: 3, 6 and 12 months after randomization
|
Pain Intensity will be measured by an 11-point (0-10) Numerical Rating Scale (Pain NRS)
|
3, 6 and 12 months after randomization
|
Function
Time Frame: Five weeks, 3, 6 and 12 months after randomization
|
Disability and function will be measured by an 11-point (0-10) Patient-Specific Functional Scale
|
Five weeks, 3, 6 and 12 months after randomization
|
Kinesiophobia
Time Frame: Five weeks, 3, 6 and 12 months after randomization
|
Kinesiophobia will be measured by the Tampa Scale of Kinesiophobia by means of 17 questions that deal with pain and intensity of symptoms.
|
Five weeks, 3, 6 and 12 months after randomization
|
Global perceived effect
Time Frame: Five weeks, 3, 6 and 12 months after randomization
|
Global perceived effect will be measured by an 11-point (-5 to +5) Global Perceived Effect Scale
|
Five weeks, 3, 6 and 12 months after randomization
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient's expectancy for improvement
Time Frame: Baseline
|
Will be assessed by the Expectancy of Improvement Numerical Scale.
|
Baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Luciola CM Costa, PhD, Universidade Cidade de Sao Paulo
Publications and helpful links
General Publications
- Garcia AN, Costa LDCM, Hancock MJ, Souza FS, Gomes GVFO, Almeida MO, Costa LOP. McKenzie Method of Mechanical Diagnosis and Therapy was slightly more effective than placebo for pain, but not for disability, in patients with chronic non-specific low back pain: a randomised placebo controlled trial with short and longer term follow-up. Br J Sports Med. 2018 May;52(9):594-600. doi: 10.1136/bjsports-2016-097327. Epub 2017 Jul 12.
- Garcia AN, Costa Lda C, Hancock MJ, de Almeida MO, de Souza FS, Costa LO. Efficacy of the McKenzie method in patients with chronic nonspecific low back pain: a protocol of randomized placebo-controlled trial. Phys Ther. 2015 Feb;95(2):267-73. doi: 10.2522/ptj.20140208. Epub 2014 Oct 2.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FAPESP200755
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Non-specific Chronic Low Back Pain
-
Iran University of Medical SciencesNot yet recruitingLow Back Pain | Chronic Low-back Pain | Chronic Non-specific Low Back Pain | Cupping Therapy
-
Cairo UniversityNot yet recruitingChronic Non Specific Low Back Pain
-
Riphah International UniversityCompletedChronic Non Specific Low Back PainPakistan
-
Riphah International UniversityRecruitingChronic Low-back Pain | Non Specific Low Back PainPakistan
-
McMaster UniversityUniversity of Alberta; Macquarie University, AustraliaCompletedChronic Low Back Pain | Non Specific Low Back PainCanada
-
Riphah International UniversityRecruitingChronic Non-specific Low Back PainPakistan
-
Peking University Third HospitalRecruitingNon-specific Chronic Low Back PainChina
-
Riphah International UniversityCompletedChronic Non-specific Low Back PainPakistan
-
Yeditepe UniversityCompletedChronic Non-specific Low Back PainTurkey
-
Taipei Medical UniversityTaiwan Resonant Waves Research Corp.Completed
Clinical Trials on Placebo
-
SamA Pharmaceutical Co., LtdUnknownAcute Bronchitis | Acute Upper Respiratory Tract InfectionKorea, Republic of
-
National Institute on Drug Abuse (NIDA)CompletedCannabis UseUnited States
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyCompletedMale Subjects With Type II Diabetes (T2DM)Germany
-
Heptares Therapeutics LimitedCompletedPharmacokinetics | Safety IssuesUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
ItalfarmacoCompletedBecker Muscular DystrophyNetherlands, Italy
-
Shijiazhuang Yiling Pharmaceutical Co. LtdXuanwu Hospital, BeijingCompleted
-
GlaxoSmithKlineCompletedInfections, BacterialUnited States
-
West Penn Allegheny Health SystemCompletedAsthma | Allergic RhinitisUnited States